NCT06557603View on ClinicalTrials.gov

Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

July 11, 2024

Study Completion Date

July 22, 2024

Conditions
Rosacea
Interventions
DRUG

Ivermectin cream

\[1 gm ± 0.030 gm\] of product was applied in a thin layer over the entire face (avoiding the eyes, lips, and mucous membranes).

DRUG

Soolantra ® (Ivermectin) cream

\[1 gm ± 0.030 gm\] of product was applied in a thin layer over the entire face (avoiding the eyes, lips, and mucous membranes).

Trial Locations (1)

390012

Cliantha Research Limited, Vadodara

All Listed Sponsors
lead

Humanis Saglık Anonim Sirketi

INDUSTRY